Answers are grounded in this paper and cite their sources.
BACKGROUND: Photon-counting detector computed tomography (PCD-CT) provides quantitative spectral and material decomposition information that may facilitate the noninvasive assessment of liver cirrhosis; however, the relative performance of PCD-CT-derived quantitative biomarkers for cirrhosis detection and severity stratification remains unclear. We aimed to evaluate PCD-CT-derived extracellular volume (ECV) fraction and other quantitative parameters, including liver fat fraction, portal venous phase iodine concentration (IC-PVP), delayed phase iodine concentration (IC-DP), normalized iodine concentration (nIC), and spectral slope, for cirrhosis assessment and functional severity stratification. METHODS: This single-center retrospective diagnostic accuracy study included 69 patients with cirrhosis and 43 control participants who underwent clinically indicated multiphasic contrast-enhanced abdominal PCD-CT between August and December 2025. Cirrhosis was confirmed histopathologically when available; otherwise, it was diagnosed using a composite clinical reference standard. Two radiologists independently measured ECV, fat fraction, iodine-based parameters, and spectral slope. Severity was assessed using Child-Pugh class, albumin-bilirubin (ALBI) grade, and Model for End-Stage Liver Disease sodium (MELD-Na) category. Logistic/ordered logistic regression and receiver operating characteristic (ROC) analyses were performed, with bootstrap resampling used to assess the internal robustness of the main ROC estimates. RESULTS: Interobserver agreement was excellent [intraclass correlation coefficient (ICC), 0.94-0.98]. ECV was the only independent marker of cirrhosis [odds ratio (OR): 1.41; 95% confidence interval (CI): 1.16-1.72; P<0.001]. It was also independently associated with increasing functional severity across Child-Pugh (adjusted OR: 1.42; 95% CI: 1.23-1.69; P<0.001), ALBI (adjusted OR: 1.33; 95% CI: 1.12-1.58; P<0.001), and MELD-Na (adjusted OR: 1.38; 95% CI: 1.11-1.72; P=0.004). The area under the curve (AUC) for cirrhosis detection was 0.85, and for severity stratification ranged from 0.85 to 0.88; bootstrap resampling supported the internal robustness of the main ROC estimates. CONCLUSIONS: PCD-CT-derived ECV was independently associated with cirrhosis and functional severity categories defined by Child-Pugh, ALBI, and MELD-Na. It may serve as a complementary quantitative biomarker during clinically indicated contrast-enhanced PCD-CT.
No takes yet. Share an insight, caveat, or question.
Tanaka et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: